Realm Therapeutics Announces Instructions for Exchanging Listed Ordinary Shares into Nasdaq listed ADSs

Wednesday, July 4, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

1

Crest reference of the trade

2

ISIN number

3

Trade Date as in Crest

4

Settlement Date as in Crest

5

Ratio (e.g.: "25:1" where 25 UK shares are

converted to 1 ADR)

6

Nominal

7

Stampable Consideration Amount - Mandatory

field for Stamp Applicable ISIN's

8

Stock Price

9

Name of Broker

10

Brokers DTC Participant Account

11

Shareholder/Client Account No. at Broker

12

Contact Person / Number

13

Result of Option Yes / No

14

CREST Participant ID

15

SDRT (please only mark one field on the right

with an "X"):

16

1.5%

17

1%

18

SDRT exempt

19

Indemnity

We shall indemnify and hold Citibank, N.A. ("the Bank")

harmless against all claims, losses, damages, costs and

expenses (including reasonable legal fees and

disbursements), penalties and taxes (including any interest

and penalties for late payment of tax) incurred by the Bank or

to which the Bank may become subject to and arising directly

from the deposit of the above securities with the Bank or the

failure by any person to pay (or discharge) any stamp duty,

stamp duty reserve tax, or any other similar duty or tax in

connection with the above securities deposited with the Bank.

If and to the extent that the deposit of the securities results

from the exercise of an option or options, we hereby represent

and warrant that the arrangements in respect of the option or

options pursuant to the exercise of which the securities are

delivered, including the timing of grant and exercise, and the

premium/strike ratio, are bona fide and commercial, and are

not motivated primarily by or for the avoidance of UK stamp

duty reserve tax.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store